Quantcast
Last updated on April 16, 2014 at 1:21 EDT

Elsevier’s SciVal Funding Expands Globally

June 24, 2011

AMSTERDAM, June 24, 2011 /PRNewswire/ –

Comprehensive Funding Tool now Available in Canada, U.K. and EU

Elsevier, a world-leading provider of scientific, technical and medical
information products and services, today announced the expansion of SciVal
Funding [http://www.info.scival.com ] to regions outside of the United
States, enabling institutions to identify international funding
opportunities.

Through the international expansion of SciVal Funding, researchers,
research administrators and research development professionals in Canada,
the United Kingdom and the European Union will now have access to relevant
funding opportunities and awarded grant data under a single integrated
solution. SciVal Funding will be expanded to Australia in August and to
Singapore, South Africa, India, New Zealand and Ireland by the end of 2011.

“Increasing funding application success rates in today’s increasingly
collaborative and international research community requires a global
perspective and access to appropriate resources,” said Niels Weertman,
Vice-President SciVal, at Elsevier. “The expanded coverage of funding
opportunities and awarded grants information of SciVal Funding highlights
Elsevier’s ongoing commitment to empower institutions worldwide to implement
performance, planning and funding strategies that are global in scope and
collaborative in nature.”

Recognizing the challenges of increased competition for funding,
Elsevier developed SciVal Funding to optimize the pre-award stage of the
research cycle. The tool leads researchers, research administrators and
research development professionals to grants with the greatest potential for
success by integrating current funding opportunities with publication
information and historical award data. Updated daily, funding opportunities
can be explored by subject area, award type, deadline or amount. Also,
SciVal Funding provides customized recommendations and alerts by matching
funding opportunity data to pre-populated researcher profiles that are
continuously updated. Research administrators may also use award information
for performance measurement, evaluation and strategic planning purposes.
Access to a comprehensive pool of funding opportunities as well as the
ability to uncover new sources of financial support is especially critical
in these uncertain economic times.

The inclusion of funding opportunities, award information and
pre-populated researcher profiles from these newly added countries, as well
as the addition of nearly 700 funding bodies to the more than 3,000
U.S.-based sources currently available in the platform, will allow
institutions to discover international funding opportunities, resulting in
more effective collaboration.

For more information on SciVal Funding and to request a trial, please
visit http://www.info.scival.com.

About the Elsevier SciVal(R) Suite

Elsevier’s SciVal suite (http://www.info.scival.com) of services
supports academic and government leadership in evaluating, establishing and
executing research strategies that optimize the performance of existing
assets and maximize investments to enhance near and long-term productivity.
SciVal tools leverage Scopus(R) data, Elsevier’s trusted source of
bibliometric data, to offer innovative yet authoritative solutions. Current
suite offerings include: SciVal Spotlight(TM), a strategic tool that
generates unique institutional and country maps of existing and emerging
strengths based on an interdisciplinary perspective of current performance;
SciVal Funding(TM), an online solution that provides targeted
recommendations on grants to pursue based on pre-populated research profiles
and historical awards; SciVal Experts, a semantic technology-based
application that enables researchers to identify and locate sources of
expertise at an individual or departmental level within and across
institutions.

About Elsevier
Elsevier is a world-leading provider of scientific, technical and medical
information products and services. The company works in partnership with the
global science and health communities to publish more than 2,000 journals,
including The Lancet [http://www.thelancet.com ] and Cell
[http://www.cell.com ], and close to 20,000 book titles, including major
reference works from Mosby and Saunders. Elsevier’s online solutions include
SciVerse ScienceDirect [http://www.sciencedirect.com ], SciVerse Scopus
[http://www.scopus.nl ], Reaxys [http://www.reaxys.com ], MD Consult
[http://www.mdconsult.com ] and Nursing Consult
[http://www.nursingconsult.com ], which enhance the productivity of science
and health professionals, and the SciVal suite [http://www.scival.com ] and
MEDai’s Pinpoint Review [http://www.medai.com ], which help research and

health care institutions deliver better outcomes more cost-effectively. A
employs 7,000 people worldwide. The company is part of Reed Elsevier Group
PLC [http://www.reedelsevier.com ], a world-leading publisher and information
provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV.
The ticker symbols are REN (Euronext Amsterdam), REL (London Stock
Exchange), RUK and ENL (New York Stock Exchange).

            Media contact
        Sandra Plasse
        +1-212-752-8338
        splasse@psbpr.com

SOURCE Elsevier


Source: newswire